Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MESH: Proto-Oncogene Proteins/chemistry"" wg kryterium: Temat


Wyświetlanie 1-7 z 7
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre-Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
MESH: Drug Design
MESH : Enzyme Inhibitors/pharmacology
MESH : Antineoplastic Agents/metabolism
MESH : Enzyme Inhibitors/metabolism
MESH : Antineoplastic Agents/pharmacology
MESH : Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Nuclear Proteins/metabolism
MESH : Animals
MESH : Nuclear Proteins/metabolism
MESH: Proto-Oncogene Proteins/chemistry
MESH: Nuclear Proteins/antagonists & inhibitors
MESH : Cell Line, Tumor
Inhibitor
[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH: Nuclear Proteins/chemistry
MESH : Protein Conformation
MESH : Antineoplastic Agents/chemical synthesis
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/metabolism
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Rats
MESH: Molecular Targeted Therapy
MESH : Molecular Docking Simulation
MESH : Proto-Oncogene Proteins/chemistry
MESH : Enzyme Inhibitors/chemical synthesis
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: Purine Nucleotides/chemical synthesis
MESH: Chemistry Techniques, Synthetic
MESH : Chemistry Techniques, Synthetic
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
MESH : Humans
MESH: Antineoplastic Agents/chemistry
MESH: Purine Nucleotides/pharmacology
MESH : Drug Screening Assays, Antitumor
MESH : Purine Nucleotides/pharmacology
MESH: Cell Line, Tumor
MESH: Molecular Docking Simulation
MESH: Animals
MESH : Antineoplastic Agents/chemistry
MESH : Nuclear Proteins/chemistry
MESH: Purine Nucleotides/chemistry
MESH: Enzyme Inhibitors/chemistry
MESH : Enzyme Inhibitors/chemistry
MESH : Proto-Oncogene Proteins/metabolism
Nucleoside analogues
MESH : Purine Nucleotides/metabolism
MESH : Purine Nucleotides/chemistry
MESH: Enzyme Inhibitors/chemical synthesis
DNPH1
MESH: Enzyme Inhibitors/metabolism
MESH: Protein Conformation
MESH : Drug Design
MESH: Proto-Oncogene Proteins/metabolism
Cross-coupling reaction
MESH: Enzyme Inhibitors/pharmacology
MESH : Purine Nucleotides/chemical synthesis
MESH: Humans
MESH: Purine Nucleotides/metabolism
MESH: Antineoplastic Agents/pharmacology
MESH : Molecular Targeted Therapy
MESH : N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/chemistry
MESH : Rats
MESH : N-Glycosyl Hydrolases/metabolism
MESH: Antineoplastic Agents/chemical synthesis
MESH : N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: Drug Screening Assays, Antitumor
Crystal structure
Cancer
MESH: Structure-Activity Relationship
MESH : Nuclear Proteins/antagonists & inhibitors
MESH : Structure-Activity Relationship
Źródło :
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. 〈10.1016/j.ejmech.2014.07.110〉
European Journal of Medicinal Chemistry
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
Cancer
Cross-coupling reaction
Crystal structure
DNPH1
Inhibitor
Nucleoside analogues
MESH: Animals
MESH: Antineoplastic Agents/chemical synthesis
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/metabolism
MESH: Enzyme Inhibitors/pharmacology
MESH: Humans
MESH: Molecular Docking Simulation
MESH: Molecular Targeted Therapy
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Nuclear Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/chemistry
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Protein Conformation
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Proto-Oncogene Proteins/chemistry
MESH: Proto-Oncogene Proteins/metabolism
MESH: Purine Nucleotides/chemical synthesis
MESH: Purine Nucleotides/chemistry
MESH: Purine Nucleotides/metabolism
MESH: Purine Nucleotides/pharmacology
MESH: Antineoplastic Agents/metabolism
MESH: Rats
MESH: Structure-Activity Relationship
MESH: Antineoplastic Agents/pharmacology
MESH: Cell Line, Tumor
MESH: Chemistry Techniques, Synthetic
MESH: Drug Design
MESH: Drug Screening Assays, Antitumor
MESH: Enzyme Inhibitors/chemical synthesis
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
Tytuł :
6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.
Autorzy :
Amiable, Claire
Paoletti, Julie
Haouz, Ahmed
Padilla, André
Labesse, Gilles
Kaminski, Pierre Alexandre
Pochet, Sylvie
Pokaż więcej
Temat :
Cancer
Cross-coupling reaction
Crystal structure
DNPH1
Inhibitor
Nucleoside analogues
MESH: Animals
MESH: Antineoplastic Agents/chemical synthesis
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/metabolism
MESH: Enzyme Inhibitors/pharmacology
MESH: Humans
MESH: Molecular Docking Simulation
MESH: Molecular Targeted Therapy
MESH: N-Glycosyl Hydrolases/antagonists & inhibitors
MESH: N-Glycosyl Hydrolases/chemistry
MESH: N-Glycosyl Hydrolases/metabolism
MESH: Nuclear Proteins/antagonists & inhibitors
MESH: Antineoplastic Agents/chemistry
MESH: Nuclear Proteins/chemistry
MESH: Nuclear Proteins/metabolism
MESH: Protein Conformation
MESH: Proto-Oncogene Proteins/antagonists & inhibitors
MESH: Proto-Oncogene Proteins/chemistry
MESH: Proto-Oncogene Proteins/metabolism
MESH: Purine Nucleotides/chemical synthesis
MESH: Purine Nucleotides/chemistry
MESH: Purine Nucleotides/metabolism
MESH: Purine Nucleotides/pharmacology
MESH: Antineoplastic Agents/metabolism
MESH: Rats
MESH: Structure-Activity Relationship
MESH: Antineoplastic Agents/pharmacology
MESH: Cell Line, Tumor
MESH: Chemistry Techniques, Synthetic
MESH: Drug Design
MESH: Drug Screening Assays, Antitumor
MESH: Enzyme Inhibitors/chemical synthesis
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
Źródło :
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2014, 85, pp.418-37. ⟨10.1016/j.ejmech.2014.07.110⟩
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies